IRIS Accounts Production v24.1.0.578 01717877 director 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh017178772022-12-31017178772023-12-31017178772023-01-012023-12-31017178772021-12-31017178772022-01-012022-12-31017178772022-12-3101717877ns15:EnglandWales2023-01-012023-12-3101717877ns14:PoundSterling2023-01-012023-12-3101717877ns10:Director12023-01-012023-12-3101717877ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3101717877ns10:SmallEntities2023-01-012023-12-3101717877ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3101717877ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3101717877ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3101717877ns10:FullAccounts2023-01-012023-12-3101717877ns10:CompanySecretary12023-01-012023-12-3101717877ns10:RegisteredOffice2023-01-012023-12-3101717877ns5:CurrentFinancialInstruments2023-12-3101717877ns5:CurrentFinancialInstruments2022-12-3101717877ns5:Non-currentFinancialInstruments2023-12-3101717877ns5:Non-currentFinancialInstruments2022-12-3101717877ns5:ShareCapital2023-12-3101717877ns5:ShareCapital2022-12-3101717877ns5:RevaluationReserve2023-12-3101717877ns5:RevaluationReserve2022-12-3101717877ns5:RetainedEarningsAccumulatedLosses2023-12-3101717877ns5:RetainedEarningsAccumulatedLosses2022-12-3101717877ns5:LandBuildings2022-12-3101717877ns5:FurnitureFittings2022-12-3101717877ns5:ComputerEquipment2022-12-3101717877ns5:LandBuildings2023-01-012023-12-3101717877ns5:FurnitureFittings2023-01-012023-12-3101717877ns5:ComputerEquipment2023-01-012023-12-3101717877ns5:LandBuildings2023-12-3101717877ns5:FurnitureFittings2023-12-3101717877ns5:ComputerEquipment2023-12-3101717877ns5:LandBuildings2022-12-3101717877ns5:FurnitureFittings2022-12-3101717877ns5:ComputerEquipment2022-12-3101717877ns5:CostValuation2022-12-3101717877ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3101717877ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3101717877ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-12-3101717877ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-12-3101717877ns5:RevaluationReserve2022-12-31017178771ns10:Director12022-12-31017178771ns10:Director12021-12-31017178771ns10:Director12023-01-012023-12-31017178771ns10:Director12022-01-012022-12-31017178771ns10:Director12023-12-31017178771ns10:Director12022-12-31
REGISTERED NUMBER: 01717877 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

OAKHAVEN RESIDENTIAL CARE HOME LIMITED

OAKHAVEN RESIDENTIAL CARE HOME LIMITED (Registered number: 01717877)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


OAKHAVEN RESIDENTIAL CARE HOME LIMITED

Company Information
for the Year Ended 31 December 2023







DIRECTOR: Mr Ralph Douglas Holland





SECRETARY: Ms Claudia Ehler





REGISTERED OFFICE: C/O Golder Baqa
Ground Floor
1 Baker's Row
London
EC1R 3DB





REGISTERED NUMBER: 01717877 (England and Wales)





ACCOUNTANTS: Golder Baqa Limited
Ground Floor
1 Baker's Row
London
EC1R 3DB

OAKHAVEN RESIDENTIAL CARE HOME LIMITED (Registered number: 01717877)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 423,653 431,711
Investments 5 176,127 176,127
599,780 607,838

CURRENT ASSETS
Debtors 6 531,629 436,291
Prepayments and accrued income 21,610 18,843
Cash at bank 67,378 41,907
620,617 497,041
CREDITORS
Amounts falling due within one year 7 224,759 212,031
NET CURRENT ASSETS 395,858 285,010
TOTAL ASSETS LESS CURRENT
LIABILITIES

995,638

892,848

CREDITORS
Amounts falling due after more than one
year

8

50,393

72,682
NET ASSETS 945,245 820,166

CAPITAL AND RESERVES
Called up share capital 100 100
Revaluation reserve 9 305,745 305,745
Retained earnings 639,400 514,321
SHAREHOLDERS' FUNDS 945,245 820,166

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

OAKHAVEN RESIDENTIAL CARE HOME LIMITED (Registered number: 01717877)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 5 April 2024 and were signed by:





Mr Ralph Douglas Holland - Director


OAKHAVEN RESIDENTIAL CARE HOME LIMITED (Registered number: 01717877)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

OAKHAVEN RESIDENTIAL CARE HOME LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of services, excluding Value Added Tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 35 (2022 - 33 ) .

OAKHAVEN RESIDENTIAL CARE HOME LIMITED (Registered number: 01717877)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. TANGIBLE FIXED ASSETS
Freehold Fixtures Office
property & fittings Equipment Totals
£    £    £    £   
COST
At 1 January 2023 706,123 268,904 55,966 1,030,993
Additions - 5,350 3,438 8,788
At 31 December 2023 706,123 274,254 59,404 1,039,781
DEPRECIATION
At 1 January 2023 290,741 256,937 51,604 599,282
Charge for year 9,790 4,952 2,104 16,846
At 31 December 2023 300,531 261,889 53,708 616,128
NET BOOK VALUE
At 31 December 2023 405,592 12,365 5,696 423,653
At 31 December 2022 415,382 11,967 4,362 431,711

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 January 2023
and 31 December 2023 176,127
NET BOOK VALUE
At 31 December 2023 176,127
At 31 December 2022 176,127

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 17,736 2,331
Other debtors 129,446 109,276
Directors' loan account 384,447 324,684
531,629 436,291

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Bank loans and overdrafts 7,774 673
Trade creditors 24,133 17,091
Corporation tax 51,921 30,256
Tax payable under S455 CTA 10 20,170 45,854
Social security and other taxes 17,841 17,998
Other creditors 3,469 3,036
Accruals and deferred income 99,451 97,123
224,759 212,031

OAKHAVEN RESIDENTIAL CARE HOME LIMITED (Registered number: 01717877)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.23 31.12.22
£    £   
Bank loans - 2-5 years 50,393 72,682

9. RESERVES
Revaluation
reserve
£   
At 1 January 2023
and 31 December 2023 305,745

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2023 and 31 December 2022:

31.12.23 31.12.22
£    £   
Mr Ralph Douglas Holland
Balance outstanding at start of year 324,684 188,762
Amounts advanced 59,763 135,922
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 384,447 324,684

11. ULTIMATE CONTROLLING PARTY

Mr Ralph Douglas Holland, the sole director of the company, controlled the company by virtue of a controlling interest (directly and indirectly) of 100% of the issued ordinary share capital.